Novel fully human IgG1 targeting folate receptor α demonstrates antitumor efficacy driven by avidity rather than monovalent binding affinity
Sci Rep. 2025 Dec 31. doi: 10.1038/s41598-025-32752-x. Online ahead of print. NO ABSTRACT PMID:41476100 | DOI:10.1038/s41598-025-32752-x
